"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","description.1","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","data_processing.5","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","age:ch1","disease:ch1","gender:ch1","tissue:ch1"
"GSM4780728","4349","GSM4780728","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 11","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","1019_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129524","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120217","NONE","11","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780729","4345","GSM4780729","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 3","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","1025_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129523","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120218","NONE","3","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780730","4369","GSM4780730","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 6","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","1055_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129522","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120219","NONE","6","medullublastoma","male","cerebrospinal fluid"
"GSM4780731","4368","GSM4780731","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 12","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","1068_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129521","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120220","NONE","12","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780732","2218","GSM4780732","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 7","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2218_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129520","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120221","NONE","7","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780733","2242","GSM4780733","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 15","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2242_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129519","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120222","NONE","15","medullublastoma","female","cerebrospinal fluid"
"GSM4780734","2243","GSM4780734","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 15","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2243_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129518","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120223","NONE","15","medullublastoma","female","cerebrospinal fluid"
"GSM4780735","2251","GSM4780735","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 9","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2251_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129558","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120224","NONE","9","medullublastoma","female","cerebrospinal fluid"
"GSM4780736","2586","GSM4780736","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 15","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2586_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129557","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120243","NONE","15","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780737","2587","GSM4780737","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 15","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2587_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129556","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120244","NONE","15","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780738","2596","GSM4780738","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 19","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2596_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129555","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120245","NONE","19","medullublastoma","male","cerebrospinal fluid"
"GSM4780739","2597","GSM4780739","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 19","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2597_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129554","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120246","NONE","19","medullublastoma","male","cerebrospinal fluid"
"GSM4780740","2634","GSM4780740","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 12","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2634_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129553","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120247","NONE","12","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780741","2763","GSM4780741","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 19","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","2763_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129552","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120248","NONE","19","medullublastoma","male","cerebrospinal fluid"
"GSM4780742","4060","GSM4780742","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 7","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4060_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129551","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120249","NONE","7","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780743","4061","GSM4780743","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 7","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4061_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129550","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120250","NONE","7","medullublastoma","male","cerebrospinal fluid"
"GSM4780744","4066","GSM4780744","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 12","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4066_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129549","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120251","NONE","12","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780745","4068","GSM4780745","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 12","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4068_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129548","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120252","NONE","12","medullublastoma","female","cerebrospinal fluid"
"GSM4780746","4080","GSM4780746","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 10","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4080_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129547","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120253","NONE","10","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780747","4092","GSM4780747","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 15","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4092_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129546","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120254","NONE","15","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780748","4093","GSM4780748","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 9","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4093_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129545","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120255","NONE","9","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780749","4152","GSM4780749","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 10","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4152_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129544","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120256","NONE","10","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780750","4168","GSM4780750","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4168_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129543","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120257","NONE","24","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780751","4169","GSM4780751","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4169_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129542","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120258","NONE","24","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780752","4189","GSM4780752","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 7","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4189_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129541","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120259","NONE","7","medullublastoma","female","cerebrospinal fluid"
"GSM4780753","4200","GSM4780753","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4200_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129577","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120260","NONE","24","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780754","4218","GSM4780754","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 7","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4218_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129576","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120261","NONE","7","medullublastoma","female","cerebrospinal fluid"
"GSM4780755","4219","GSM4780755","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 10","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4219_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129575","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120262","NONE","10","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780756","4225","GSM4780756","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 5","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4225_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129574","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120263","NONE","5","medullublastoma","female","cerebrospinal fluid"
"GSM4780757","4233","GSM4780757","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4233_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129573","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120264","NONE","24","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780758","4237","GSM4780758","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 13","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4237-846_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129572","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120265","NONE","13","medullublastoma","female","cerebrospinal fluid"
"GSM4780759","4238","GSM4780759","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4238_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129571","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120266","NONE","24","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780760","4249","GSM4780760","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 7","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4249_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129570","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120267","NONE","7","medullublastoma","female","cerebrospinal fluid"
"GSM4780761","4253","GSM4780761","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4253_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129569","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120268","NONE","24","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780762","4258","GSM4780762","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4258_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129568","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120269","NONE","24","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780763","4270","GSM4780763","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 5","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4270_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129567","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120270","NONE","5","medullublastoma","female","cerebrospinal fluid"
"GSM4780764","4277","GSM4780764","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 5","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4277_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129566","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120271","NONE","5","medullublastoma","female","cerebrospinal fluid"
"GSM4780765","4281","GSM4780765","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 5","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4281_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129565","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120272","NONE","5","medullublastoma","female","cerebrospinal fluid"
"GSM4780766","4283","GSM4780766","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 11","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4283_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129564","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120273","NONE","11","medullublastoma","female","cerebrospinal fluid"
"GSM4780767","4284","GSM4780767","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 11","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4284_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129563","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120274","NONE","11","medullublastoma","female","cerebrospinal fluid"
"GSM4780768","4319","GSM4780768","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 3","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4319_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129562","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120225","NONE","3","medullublastoma","female","cerebrospinal fluid"
"GSM4780769","4353","GSM4780769","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 14","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4353-611_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129561","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120226","NONE","14","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780770","4351","GSM4780770","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 9","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","565_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129560","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120227","NONE","9","medullublastoma","male","cerebrospinal fluid"
"GSM4780771","4352","GSM4780771","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 10","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","566_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129559","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120228","NONE","10","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780772","4370","GSM4780772","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 6","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","570_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129585","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120229","NONE","6","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780773","4359","GSM4780773","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 6","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","584_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129584","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120230","NONE","6","medullublastoma","female","cerebrospinal fluid"
"GSM4780774","4358","GSM4780774","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 8","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","585_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129583","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120231","NONE","8","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780775","4346","GSM4780775","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 6","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","624_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129582","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120232","NONE","6","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780776","4355","GSM4780776","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 18","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","670_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129581","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120233","NONE","18","medullublastoma","male","cerebrospinal fluid"
"GSM4780777","4361","GSM4780777","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 3","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","673_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129580","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120234","NONE","3","medullublastoma","male","cerebrospinal fluid"
"GSM4780778","4356","GSM4780778","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 15","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","779_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129579","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120235","NONE","15","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780779","4347","GSM4780779","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 11","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","912_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129578","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120236","NONE","11","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780780","4343","GSM4780780","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 3","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","939_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129540","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120237","NONE","3","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780781","4348","GSM4780781","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: male","age: 6","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","953_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129538","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120238","NONE","6","medulloblastoma with leptomeningeal metastasis","male","cerebrospinal fluid"
"GSM4780782","4344","GSM4780782","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 3","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","971_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129536","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120239","NONE","3","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780783","2246","GSM4780783","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 14","disease: medullublastoma","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","re-2246_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129535","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120240","NONE","14","medullublastoma","female","cerebrospinal fluid"
"GSM4780784","2247","GSM4780784","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 14","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","re-2247_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129534","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120241","NONE","14","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
"GSM4780785","4231","GSM4780785","Public on Sep 15 2020","Sep 14 2020","Sep 16 2020","SRA","1","cerebrospinal fluid","Homo sapiens","tissue: cerebrospinal fluid","gender: female","age: 24","disease: medulloblastoma with leptomeningeal metastasis","total RNA","CSF exosome was precipitated using Exo2DTM for RNA assay (EXOSOME plus, Suwon, South Korea) according to the manufacture’s protocol (Kim, et al. 2017). 2 ml of CSF were added to Exo2DTM reagent B following mixing by inverting, and incubated at room temperature for 30 min. The supernatant was discarded and the exosome containing pellet was resuspended in 100 ul of PBS to further RNA isolation.  Total RNA was extracted from the CSF exosome fraction using a microRNA purification kit (Norgen Biotek corp., Thorold, Canada) according to the manufacture’s protocol. Briefly, samples were mixed with lysis buffer, and the lysate was added to absolute ethanol. The lysate was applied up to the column and centrifuged at 8,000 rpm for 1 min. The column was washed with wash solution and centrifuged at 14,000 rpm for 1 min. Finally, the column was applied to 20 ul of elution solution and centrifuged at 14,000 rpm for 2 min, and the flow-through was stored at –80 ℃ for storage.","The samples were quantified and qualified with Bioanalyzer Pico 6000 Chip (Agilent Technologies, Santa Clara, CA). The 10 ng of total RNA was provided to the cDNA library generation using SMARTer smRNA-Seq kit (Illumina Inc., San Diego, CA). The cDNA library was subjected to sequencing using Truseq SBS Kit and HiSeq 2500 System (Illumina Inc., San Diego, CA)","9606","exosomal RNA","4231Exo-Exoplus_Read_Count","The raw sequence reads are filtered based on quality using FastQC v0.11.7.","The adapter sequences are also trimmed off adapter sequences, primers, poly-A tails and other types of unwanted sequence using Cutadapt 1.16.","The reads were aligned to the 45S pre-rRNA and mitochondrial rRNA of hg19 reference genome and have them removed.","mature miRNA Quantification procedure. 1) mature miRNA sequences of relevant species are aligned to precursor miRNA sequences from miRBase v21 (bowtie option : -f -v 0 -a  --best --strata --norc). 2) unique clustered reads are aligned to precursor sequence (bowtie option : -f -v 1 -a --best --strata --norc). Bowtie aligner is used in the mapping  steps. 3) overlapping mature miRNA regions between two mapping results were determined. Afterwards, the read count of mature miRNAs are extracted from the overlapping regions in  the miRDeep2 Quantifier module. If a read is mapped to multiple mature miRNAs, the read counts are assigned equally to the abundance level of each mature miRNA.","Genome_build: hg19 by Bowtie and STAR, miRBase v21 by miRDeep2","Supplementary_files_format_and_content: Matrix table with raw gene counts for mature miRNA","GPL16791","Ho-Shin,,Gwak","nsghs@ncc.re.kr","Department of Cancer Control","National Cancer Center Graduate School of Cancer Science and Policy","323 Ilsan-ro","Goyang","10408","South Korea","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16129533","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9120242","NONE","24","medulloblastoma with leptomeningeal metastasis","female","cerebrospinal fluid"
